Low molecular weight heparin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
##[[PE]] | ##[[PE]] | ||
##[[NSTEMI]] | ##[[NSTEMI]] | ||
##[[STEMI | ##[[STEMI]] | ||
==Source == | ==Source == | ||
Revision as of 07:23, 21 October 2011
Background
- Similar mechanism of action as heparin but with predictable effect
- Advantages over unfractionated heparin:
- More reliable level of anticoagulation
- No need for monitoring w/ PTT
- Decreased incidence of HIT
- Can give as oupt
- Disadvantages compared to unfractionated heparin:
- Renally excreted; may accumulate in pts w/ renal impairment leading to bleeding
- Longer half-life
Dosing
- Renal impairment (Cr clearance <30)
- Use 50% of usual dose or use UFH instead
- Obesity
- Weight-based dosing safe up to 190kg (no data available thereafter)
Treatment
Source
Tintinalli
